Clinical and molecular characteristics of early progressors (EPs) and long-term progression-free survivors (LTPs) from the phase 3 ADRIATIC trial of consolidation durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC)

Barbie D. A., Xie M., Broggi M., Cheng Y., Spigel D. R., Cho B. C., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.43, sa.16_SUPPL, 2025 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 43 Sayı: 16_SUPPL
• Basım Tarihi: 2025
• Doi Numarası: 10.1200/jco.2025.43.16_suppl.8014
• Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Nature Index
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır